Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay CTA Index gains 0.48% in December; Managed Futures down 1.64% in 2012

Tuesday, January 15, 2013
Opalesque Industry Update: Managed futures gained 0.48% in December according to the Barclay CTA Index compiled by BarclayHedge. The Index ended 2012 with a loss of 1.64%.

“The main drivers of returns last month were the uptrend in global equities and the continued weakening of the Japanese yen,” says Sol Waksman, founder and president of BarclayHedge.

Seven of Barclay’s eight CTA indices had a positive return in December. The Diversified Traders Index was up 0.58%, Systematic Traders gained 0.58%, Financial & Metals Traders added 0.57%, and Currency Traders gained 0.35%.

The only losing strategy in December was the Agricultural Traders Index, which was down 0.57% for the month.

“Wheat prices dropped 10.3 percent and corn lost 7.4 percent,” says Waksman. “It was costly if you were positioned on the wrong side of either of these moves."

The Barclay BTOP50 Index, which measures performance of the largest CTAs, gained 0.45% in December, but lost 1.84% in 2012.

The Agricultural Traders Index was up 9.82% at the end of August, but after four straight months of losses, ended the year with a return of 5.40%. CTAs trading Agricultural markets were still the most successful managers in 2012.

Currency Traders had a 1.59% return in 2012, and Discretionary Traders were up 1.39% at year end.

On the losing side of the ledger, the Diversified Traders Index gave up 3.94% in 2012, Systematic Traders lost 3.11%, and the Financial & Metals Traders Index was down 2.74%.

For the first time in 33 years, the Barclay CTA Index recorded losses for two years in a row, down 3.09% in 2011, followed by losses of 1.64% in 2012.

“Over the past two years, there have been primarily only two trades to make; either risk-on or risk-off,” says Waksman.

“The main market sectors for CTAs – equities, interest rates, currencies, and commodities – would see prices change direction based on unpredictable government actions and announcements. It’s been a difficult environment for traders.”

BarclayHedge

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its